ABPYX
Price
$13.10
Change
-$0.01 (-0.08%)
Updated
Oct 17 closing price
Net Assets
87.19M
RLBCX
Price
$38.75
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

ABPYX vs RLBCX

Header iconABPYX vs RLBCX Comparison
Open Charts ABPYX vs RLBCXBanner chart's image
AB Sustainable Thematic Bal Port Advisor
Price$13.10
Change-$0.01 (-0.08%)
VolumeN/A
Net Assets87.19M
American Funds American Balanced R3
Price$38.75
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
ABPYX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
ABPYX vs. RLBCX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABPYX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 265B vs. ABPYX (87.2M). RLBCX pays higher dividends than ABPYX: RLBCX (1.49) vs ABPYX (1.41). ABPYX was incepted earlier than RLBCX: ABPYX (22 years) vs RLBCX (23 years). ABPYX (0.92) and RLBCX (0.89) have similar cost to investors . ABPYX is a more actively managed with annual turnover of: 53.00 vs. RLBCX (44.00). ABPYX has a lower initial minimum investment than RLBCX: ABPYX (0) vs RLBCX (250). RLBCX annual gain was more profitable for investors over the last year : 8.34 vs. ABPYX (2.85). RLBCX return over 5 years is better than : 40.24 vs. ABPYX (13.60).
ABPYXRLBCXABPYX / RLBCX
Total Expense Ratio0.750.8984%
Annual Report Gross Expense Ratio0.920.89103%
Fund Existence22 years23 years-
Gain YTD7.37714.36451%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets87.2M265B0%
Annual Yield % from dividends1.411.4995%
Returns for 1 year2.858.3434%
Returns for 3 years31.2349.2663%
Returns for 5 years13.6040.2434%
Returns for 10 years29.0872.1840%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBM3.520.07
+2.03%
Psyence Biomedical Ltd
CVGW23.810.14
+0.59%
Calavo Growers
SWK67.85-0.06
-0.09%
Stanley Black & Decker
IQ2.03-0.03
-1.46%
iQIYI
PMVP1.40-0.04
-2.78%
PMV Pharmaceuticals